Downey, L C
Cotten, C M
Hornik, C P
Laughon, M M
Tolia, V N
Clark, R H
Smith, P B
Article History
Received: 5 August 2016
Revised: 3 November 2016
Accepted: 23 November 2016
First Online: 26 January 2017
Competing interests
: CPH receives salary support for research from the National Center for Advancing Translational Sciences of the National Institutes of Health (UL1TR001117). ML is supported by the US government for his work in pediatric and neonatal clinical pharmacology (HHSN267200700051C (Principal Investigator: Benjamin)), National Institute of Child Health and Human Development (K23 HD068497) and the National Heart, Lung, and Blood Institute (R34 HL124038). PBS receives salary support for research from the National Institutes of Health (NIH) and the National Center for Advancing Translational Sciences of the NIH (1R21HD080606-01A1 and UL1TR001117), the National Institute of Child Health and Human Development (HHSN275201000003I and 1R01-HD081044-01) and the Food and Drug Administration (1R18-FD005292-01); he also receives research support from Cempra Pharmaceuticals (subaward to HHS0100201300009C) and industry for neonatal and pediatric drug development (ExternalRef removed). All other authors declare no conflicts of interest.